Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 3 August 1973:
Vol. 181. no. 4098, pp. 456 - 457
DOI: 10.1126/science.181.4098.456
Prev | Table of Contents | Next

Articles

6-Hydroxydopamine: Evidence for Superoxide Radical as an Oxidative Intermediate

Richard E. Heikkila 1 and Gerald Cohen 1

1 Department of Neurology, College of Physicians & Surgeons of Columbia University, 640 West 168 Street, New York 10032

Superoxide dismutase inhibited the autoxidation of 6-hydroxydopamine as measured by the rate of formation of a quinone and the rate of oxygen consumption. These observations demonstrate the formation of the superoxide radical during the autoxidation process. This finding may be relevant to the mechanism of adrenergic nerve terminal degeneration caused by 6-hydroxydopamine.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The Autoxidation of Tetrahydrobiopterin Revisited: PROOF OF SUPEROXIDE FORMATION FROM REACTION OF TETRAHYDROBIOPTERIN WITH MOLECULAR OXYGEN.
M. Kirsch, H.-G. Korth, V. Stenert, R. Sustmann, and H. de Groot (2003)
J. Biol. Chem. 278, 24481-24490
   Abstract »    Full Text »    PDF »
Adrenergic Hyperactivity and Metanephrine Excess in the Nucleus Accumbens After Prefrontocortical Dopamine Depletion.
E. F. Espejo and J. Minano (2001)
J Neurophysiol 85, 1270-1274
   Abstract »    Full Text »    PDF »
Antioxidant Therapy: A New Pharmacological Approach in Shock, Inflammation, and Ischemia/Reperfusion Injury.
S. Cuzzocrea, D. P. Riley, A. P. Caputi, and D. Salvemini (2001)
Pharmacol. Rev. 53, 135-159
   Abstract »    Full Text »    PDF »
Immortalized Dopamine Neurons: A Model to Study Neurotoxicity and Neuroprotection.
E. D. Clarkson, J. Edwards-Prasad, C. R. Freed, and K. N. Prasad (1999)
Experimental Biology and Medicine 222, 157-163
   Abstract »    Full Text »
Oxidative stress, glutamate, and neurodegenerative disorders.
J. Coyle and P Puttfarcken (1993)
Science 262, 689-695
   Abstract »    PDF »
The Parkinsonism-inducing Drug 1-Methyl-4-phenylpyridinium Triggers Intracellular Dopamine Oxidation. A NOVEL MECHANISM OF TOXICITY.
J. Lotharius and K. L. O'Malley (2000)
J. Biol. Chem. 275, 38581-38588
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)